YOU WONT BELIEVE: Deane dray - You Need To See This

3M's Modest Results Win Analyst Praise, But PFAS Litigation Risk Looms

RBC Capital analyst Deane Dray raised the price target for the post-it maker 3M Company (NYSE:MMM) from $120 to $130, while keeping an Underperform rating.

Benzinga · Oct 22, 2025

Danaher's Defensive Portfolio Is Ideal Amid Macro Fears: RBC Analyst

Danaher Corporation’s (NYSE: DHR) portfolio, with 75% recurring revenues and more than a 90% mix in life sciences and diagnostics, appears “incrementally more attractive” amid the currently harsh macro environment, according to RBC Capital Markets.

Benzinga · Jun 1, 2022